We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Agenda
- Why prevention matters: A global imperative
- What is preventive health economics?
- Typology of preventive interventions
- "There is no glory in prevention"
- The economics of prevention: Key concepts
- ROI across public health interventions
- Case study: Johnson & Johnson wellness program
- Interpreting ROI: Cautions
- Opportunity costs in prevention
- Cost-saving, cost-effective, ROI
- Designing for ROI: What works?
- Real-world barriers
- Policy implications
- Summary: Why prevention pays
- Conclusion
This material is restricted to subscribers.
Topics Covered
- Vaccines
- Wellness programs
- Investment
- Healthcare system
- Public health
- Underinvestment
- Absenteeism
- Reallocating budget
Talk Citation
Strametz, R. (2026, June 30). Preventive health economics: investing in population health [Video file]. In The Business & Management Collection, Henry Stewart Talks. Retrieved July 1, 2026, from https://doi.org/10.69645/QTHG3483.Export Citation (RIS)
Publication History
- Published on June 30, 2026
Other Talks in the Series: Healthcare Economics
Transcript
Please wait while the transcript is being prepared...
0:00
Welcome to this Henry
Stewart Talk on
Preventive Health Economics:
Investing in Population Health.
My name is Reinhard Strametz.
I'm a professor at RheinMain
University in Wiesbaden.
In this session, we
will explore one of
the most vital and timely
areas in health economics,
the financial return
on investment
or ROI of preventive
health initiatives.
0:23
In an era of increasing
healthcare costs,
aging populations and
strained budgets,
prevention is not a
luxury; it's a necessity.
We'll examine how interventions
like vaccinations,
workplace wellness programs and
early screenings do more
than improve public health.
They reduce the need for
expensive treatments,
increase economic
productivity, and
strengthen the resilience
of healthcare systems.
Prevention is one of
the rare strategies
that offers a triple win:
better health outcomes,
lower long-term costs, and
increased social equity.
Using real-life case studies
and evidence-based data,
I'll show you how preventive
health can be evaluated
not just in terms of
clinical success,
but as a smart
financial investment.
Our aim is to shift
the mindset from
paying for care to
investing in health.
Let's begin this journey into
the economics of
population health.
1:21
Before we begin, you
might have noticed
the image of Benjamin
Franklin on this slide.
That's not a coincidence,
and by the end of this talk,
I'll explain exactly why
he's here and why his words
continue to shape
how we think about
prevention even in
modern health economics.
Noncommunicable diseases
like heart disease, cancer,
diabetes, and chronic
respiratory conditions are
responsible for more than
70% of global deaths.
Many of these conditions
are preventable or
can be delayed through simple,
cost-effective interventions.
Despite this, healthcare
systems around the world
continue to prioritize
acute, curative care.
Hospitals are built,
surgeries are scheduled,
and medications are prescribed
often at great expense.
But too little is invested in
stopping disease
before it begins.
Economically, the cost of
preventable illness
is staggering.
Chronic disease drains
natural healthcare budgets,
increases out-of-pocket
expenses for families,
and reduces workforce
productivity.
The World Economic
Forum estimates that
noncommunicable diseases
could cost the global economy
over $47 trillion
between 2010 and 2030.
Prevention, in contrast,
has the power to flatten
this rising curve,
both in terms of
disease burden and
financial strain.
School-based education
programs, tobacco taxation,
access to vaccines, and
healthy urban planning
can all generate measurable
health and economic returns.
Just in case you're not familiar
with Benjamin Franklin,
he was one of the
founding fathers of
the United States, a
scientist, diplomat, and a man
deeply concerned with public
health and civic planning.
His insights into prevention
weren't just philosophical.
It was pragmatic;
more on that soon.